2nd Annual Oxford Global Biosimilars and Biobetters Congress 2014 London

  • Conference Call
  • Co-​located with the 7th Annual Pro­teins and Anti­bod­ies Con­gress and the Pep­tides Con­gress Oxford Global are proud to present the 2nd Annual Biosim­i­lars and Bio­bet­ters Con­gress 2014, tak­ing place on 3 – 4 April 2014 at Novo­tel Lon­don West, Lon­don, United King­dom.

    The fol­low on bio­log­ics indus­try is fore­cast to reach $8.8 bil­lion by 2017. Our con­fer­ence pro­gramme focuses on the chal­lenges, inno­va­tions and tech­nolo­gies that promise to put this sec­tor at the fore­front of the phar­ma­ceu­ti­cal industry.

    Con­gress Topics

    The 2nd Annual Biosim­i­lars and Bio­bet­ters Con­gress fea­tures two streams:

    Mar­ket Oppor­tu­ni­ties & Com­mer­cial Chal­lenges: In Stream 1, the meet­ing will address the most press­ing chal­lenges in gain­ing access to emerg­ing mar­kets and brand­ing biosim­i­lars through a series of cutting-​edge con­fer­ence pre­sen­ta­tions. Our boisim­i­lars experts will also debate how to over­come reg­u­la­tory chal­lenges, out­source man­u­fac­tur­ing and develop pric­ing strategies.

    • Oppor­tu­ni­ties and chal­lenges in emerg­ing markets
    • Global reg­u­la­tory chal­lenges and developments
    • Com­mer­cial­is­ing and brand­ing biosimilars
    • Pric­ing strate­gies and risk reduc­tion strategies
    • Out­sourc­ing and con­tract manufacturing
    • Sub­sti­tu­tion and inter­changa­bil­ity of biosimilars
    • Mar­ket access initiatives
    • Tech­no­log­i­cal advances

    Devel­op­ing Biosim­i­lars & Bio­bet­ters: Learn more about cur­rent devel­op­ments in clin­i­cal tri­als, includ­ing phar­ma­covig­i­lence and patient safety. Do not miss out on the chance to dis­cover inno­v­a­tive solu­tions for achiev­ing qual­ity by design, demon­strat­ing biosim­i­lar­ity and address­ing potency as well as the lat­est insights into the reg­u­la­tory require­ments and trial design.

    • Over­com­ing the chal­lenges of immunogenicity
    • Com­plex pro­teins as biosim­i­lars: the mon­o­clonal anti­body opportunity
    • Patient safety: trial design and patient enrolment
    • Clin­i­cal pro­to­col and reg­u­la­tory updates
    • Demon­strat­ing biosim­i­lar­ity and characterisation
    • Devel­op­ing suc­cess­ful biobetters
    • Assess­ing rel­a­tive potency
    • PK/​PD testing
    • Qual­ity by Design

    Con­firmed Speakers

    • Peter de Veene – EU Qual­i­fied Per­son for Phar­ma­covig­i­lance, Roche
    • Richard DiCi­c­cio – Chair­main of the Board, Har­vest Moon Pharmaceuticals
    • Sheka Ganese – Sci­en­tific Direc­tor, Genzyme
    • JiJie Gu – Prin­ci­pal Sci­en­tist, Abbott
    • Jason Li – Sci­en­tific Direc­tor, Genor Biopharma
    • Bernd Liedert – Direc­tor, Head of Immunophar­ma­col­ogy, Merck Serono
    • Mohamed Oubihi – Asso­ciate Direc­tor, Reg­u­la­tory Affairs, Abbott
    • Hans Rogl – Asso­ciate Direc­tor, Pro­tein Sci­ence, Purifi­ca­tion and For­mu­la­tion, Boehringer Ingelheim
    • Angela Thomas – Chair of Bio­log­i­cals and Vac­cines Expert Advi­sory Group-​Comission on Human Med­i­cines, MHRA
    • Jaap Ven­ema – Ther­a­peu­tic Area Lead Bio­ther­a­peu­tics, AbbVie
    • Nils Wilk­ing – Pro­fes­sor, Karolin­ska Insitute
    • Jian­guo Yang – Prin­ci­pal Sci­en­tist, Senior Man­ager, Genzyme

    Who Will Attend

    The Biosim­i­lars & Bio­bet­ters Con­gress is an exclu­sive event designed for senior level atten­dees from lead­ing phar­ma­ceu­ti­cal, bio­phar­ma­ceu­ti­cal, biotech­nol­ogy, diag­nos­tics, CRO and solu­tion provider com­pa­nies, along with highly esteemed mem­bers of aca­d­e­mic and gov­ern­ment institutions.

    Del­e­gates typ­i­cally include VPs, Direc­tors and Global Heads of:

    • Bio­an­a­lyt­ics, Bio­bet­ters, Biosimilars
    • Biotech Inno­va­tion, Biotherapeutics
    • Clin­i­cal Devel­op­ment, CMC Strategy
    • Immuno­genic­ity Testing
    • Mar­ket Entry, Part­ner­ing and Licensing
    • Patient Safety
    • Phar­ma­covig­i­lence
    • Port­fo­lio Devel­op­ment, Prod­uct Development
    • Pro­tein Characterisation
    • Qual­ity Assur­ance, Reg­u­la­tory Affairs
    • Sourc­ing and Sup­ply, Trial Design

    Sub­mit a poster

    For atten­dees inter­ested in sub­mit­ting a poster, there are oppor­tu­ni­ties now avail­able. Your poster pre­sen­ta­tion will be located in the exhi­bi­tion room for two days along­side other posters from senior sci­en­tists from the phar­ma­ceu­ti­cal indus­try and aca­d­e­mic institutions.

    How to sub­mit your abstract

    We will require:

    • Poster title, Abstract (200 words or less)
    • Prin­ci­pal author, Organisation
    • Mail­ing address, Email, Tele­phone, Fax
    • Addi­tional authors

    In order to secure your board space a fee of £125 will be required. The poster should be pre­sented as A0 (841mm x 1189mm) por­trait size. To take advan­tage of this oppor­tu­nity you need to be reg­is­tered as a paid del­e­gate over the 2 days. We have lim­ited spaces avail­able, so please reg­is­ter soon!

    starting: ending: 06.04.2014 Location: , Category:

    Timeline

    Conference START 06.04.2014 END

    All deadlines have expired!

    This conference has no more open deadlines. There may be successive conferences coming up you may by interested in.

    Please check our conference list and search...

    Conference Facts

    Location , Address Novotel London West, Shortlands 1 Category Organiser More Info Conference Website

    Further interesting Conferences

    Currently we have no similar events listed. Please check our website regulary, subscribe to our RSS-Feed or follow us on twitter for new listings.